FR1121M - Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy. - Google Patents

Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.

Info

Publication number
FR1121M
FR1121M FR858383A FR858383A FR1121M FR 1121 M FR1121 M FR 1121M FR 858383 A FR858383 A FR 858383A FR 858383 A FR858383 A FR 858383A FR 1121 M FR1121 M FR 1121M
Authority
FR
France
Prior art keywords
isoniazid
leprosy
tuberculosis
treatment
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858383A
Other languages
French (fr)
Inventor
Albert German
Tran Ba Loc
Painvin Nee Yvonne Fremin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAINVIN
TRAN BA LOC
Original Assignee
PAINVIN
TRAN BA LOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAINVIN, TRAN BA LOC filed Critical PAINVIN
Priority to FR858383A priority Critical patent/FR1121M/en
Application granted granted Critical
Publication of FR1121M publication Critical patent/FR1121M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR858383A 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy. Expired FR1121M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR858383A FR1121M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858383A FR1121M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.

Publications (1)

Publication Number Publication Date
FR1121M true FR1121M (en) 1962-02-12

Family

ID=87884472

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858383A Expired FR1121M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.

Country Status (1)

Country Link
FR (1) FR1121M (en)

Similar Documents

Publication Publication Date Title
NL148313B (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC PREPARATIONS, AND FOR THE PREPARATION OF SUITABLE N-SUBSTITUTED LACTAMS.
FR1121M (en) Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.
FR2075M (en) New derivatives of 6-methyl- and 1,6-dimethyl-ergoline i.
FR1302320A (en) Modified polymers of 1,2-epoxyhydrocarbons and their preparation
NL172446C (en) PROCESS FOR THE PREPARATION OF 4-ARYL-1- (4,4-DIARYLBUTYL) 4-HYDROXYPIPERIDINES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL174462B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH AN ACTION AGAINST FUNGI AND BACTERIA, AND PROCESS FOR THE PREPARATION OF PHENETHYLIMIDAZOLS USE THEREOF
NL7609028A (en) PROCESS FOR THE PREPARATION OF INSECTICIDE AND ACARICIDE PREPARATIONS.
BE617209A (en) Dyes derived from symmetrical 4-halo-4'.4 "-diarylamino-triphenylmethanes and their preparation
FR1120M (en) Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.
NL7511943A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON 1,2-DIPHENYLETHANOLS AND THEIR USE AS AN ANTI-IGNITION AGENT.
ES203614Y (en) SET OF ARTICULATED RODS AND RODS, PERFECTED.
FR2281M (en) Esters of 17α-ethynylestr-5 (10) -ene-3β, 17β-diol.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
BE613688A (en) 6,16-17-oxygenated dialkylprogesterones and processes for their preparation
FI36865A (en) Method 10.11-substituted 5-sec. for the preparation of aminoalkyliminodibenzyls and iminobilylenes
FR2260M (en) 16 alpha-chloroprednisolone derivatives and therapeutic compositions containing them.
BE599031A (en) Therapeutic agents derived from morphine and their preparation.
FR1893M (en) Derivatives of 4-quinazolone and 2,4-quinazolinedione which can be used as anti-hypertensive drugs.
BE623044A (en) Pteridine derivatives, their preparation and use.
BE613979A (en) Tetracyano-benzoquinone- (1.4) and its preparation process
FR1778M (en) Combination of 2,2-diphenyl-4-hexamethylenimino-butyramide methyliodide, phenyl-amino-propanol and n-4-chlorbenzhydryl-n'-cinnamyl-piperazine.
BE613226A (en) 1.2.4-Benzothiadiazine derivatives and their preparation
BE617616A (en) Polyhydrophenanthrene derivatives, pharmaceutical compositions containing them and their preparation.
BE604996A (en) 1,2,3,4-tetrahydroquinazolinone derivatives and their preparation
BE624729A (en) New derivatives 6-methylergoline and 1,6-dimethylergoline.